Prasugrel Mylan 10 mg film-coated tablets

DRUG2 trials

Sponsors

Rigshospitalet, Azienda Ospedaliera Universitaria Gaetano Martino Messina, Azienda Ospedaliera Universitaria Gaetano Martino Messina

Conditions

Acute coronary syndromeMyocardial infarction

Phase 3

De-Escalation of Antiplatelet Therapy to Evaluate Platelet Reactivity and Clinical Outcomes after Coronary Stenting in Patients at High Bleeding Risk and Recent Acute Coronary Syndrome: DESC-HBR trial

RecruitingCTIS2023-509868-20-00

Azienda Ospedaliera Universitaria Gaetano Martino Messina, Azienda Ospedaliera Universitaria Gaetano Martino MessinaAcute coronary syndrome

Start: 2023-06-24Target: 200Updated: 2024-05-14

Phase 4

Reduced antithrombotic strategy for high bleeding risk patients with myocardial infarction treated with percutaneous coronary intervention - The Dan-DAPT trial

RecruitingCTIS2022-500125-32-00

RigshospitaletMyocardial infarction

Start: 2022-06-20Target: 2700Updated: 2025-11-18

Related Papers

Genotype-guided de-escalation and abbreviation of dual antiplatelet therapy in patients with myocardial infarction and high bleeding risk: Design and rationale of the investigator-initiated, multicenter, randomized, controlled trial, DAN-DAPT.

2025-02-262 citations